|
magnetic resonance imaging |
52 |
|
mri |
39 |
|
deep learning |
37 |
|
artificial intelligence |
36 |
|
humans |
34 |
|
nasopharyngeal carcinoma |
34 |
|
male |
31 |
|
covid-19 |
28 |
|
machine learning |
28 |
|
middle aged |
26 |
|
radiomics |
26 |
|
diffusion-weighted imaging |
25 |
|
prognosis |
25 |
|
female |
24 |
|
atherosclerosis |
23 |
|
computed tomography |
23 |
|
pet/ct |
23 |
|
adult |
22 |
|
chinese |
22 |
|
intravoxel incoherent motion |
21 |
|
brain |
20 |
|
imaging |
19 |
|
sars-cov-2 |
19 |
|
cervical cancer |
18 |
|
diffusion tensor imaging |
18 |
|
positron emission tomography |
18 |
|
adc |
17 |
|
dementia |
16 |
|
anosmia |
15 |
|
cancer |
15 |
|
chemoradiotherapy |
15 |
|
dce-mri |
15 |
|
diffusion magnetic resonance imaging |
15 |
|
lung cancer |
15 |
|
olfactory dysfunction |
15 |
|
randomized controlled trial |
15 |
|
cardiovascular magnetic resonance |
14 |
|
diffusion kurtosis imaging |
14 |
|
esophageal squamous cell carcinoma |
14 |
|
neoadjuvant therapy |
14 |
|
perfusion |
14 |
|
quality of life |
14 |
|
rheumatoid arthritis |
14 |
|
type 2 diabetes |
14 |
|
alzheimer's disease |
13 |
|
positron-emission tomography |
13 |
|
standardized uptake value |
13 |
|
stroke |
13 |
|
cone-beam computed tomography |
12 |
|
magnetic resonance spectroscopy |
12 |
|
mind-body intervention |
12 |
|
non-small cell lung cancer |
12 |
|
outcome |
12 |
|
thyroiditis |
12 |
|
aging - pathology |
11 |
|
anisotropy |
11 |
|
brain - pathology |
11 |
|
hepatocellular carcinoma |
11 |
|
immunotherapy |
11 |
|
intensity-modulated radiation therapy |
11 |
|
liquid biopsy |
11 |
|
mrs |
11 |
|
sensitivity and specificity |
11 |
|
thyroid function tests |
11 |
|
thyroid gland |
11 |
|
aging |
10 |
|
brain microstructure |
10 |
|
cognition |
10 |
|
cognitive behavioral therapy |
10 |
|
coronary artery disease |
10 |
|
delusional disorder |
10 |
|
diffusion |
10 |
|
f-dopa |
10 |
|
family caregiver |
10 |
|
first-episode psychosis |
10 |
|
functional connectivity |
10 |
|
functional outcome |
10 |
|
generative ai |
10 |
|
hong kong |
10 |
|
intracranial germ cell tumor |
10 |
|
magnetic resonance imaging - methods |
10 |
|
magnetization transfer |
10 |
|
multidetector computed tomography |
10 |
|
negative symptoms |
10 |
|
neurotoxicity |
10 |
|
obesity |
10 |
|
ovarian cancer |
10 |
|
plasma ebv dna |
10 |
|
radiation therapy |
10 |
|
risk factors |
10 |
|
schizophrenia |
10 |
|
smell impairment |
10 |
|
striatal dopamine capacity synthesis |
10 |
|
targeted therapy |
10 |
|
treatment outcome |
10 |
|
18f-fdg pet/ct |
9 |
|
4d flow |
9 |
|
aged |
9 |
|
chest x-ray |
9 |
|
cognitive behavioural therapy |
9 |
|
contrast-enhanced ct |
9 |
|
diagnosis |
9 |
|
diagnosis, differential |
9 |
|
dw-mri |
9 |
|
family caregivers |
9 |
|
head and neck cancer |
9 |
|
large language models |
9 |
|
medical imaging |
9 |
|
nomogram |
9 |
|
observer variation |
9 |
|
prediction model |
9 |
|
prevalence |
9 |
|
radiology |
9 |
|
recursive partitioning analysis |
9 |
|
resting-state fmri |
9 |
|
stage classification |
9 |
|
survival |
9 |
|
survival prediction |
9 |
|
tumors |
9 |
|
vitamin a |
9 |
|
white cell count |
9 |
|
18f-fdg pet |
8 |
|
3d superresolution |
8 |
|
aerosolised |
8 |
|
alzheimer’s disease |
8 |
|
breast cancer |
8 |
|
cardiovascular diseases |
8 |
|
case-control studies |
8 |
|
chemotherapy |
8 |
|
circulating neoplastic cell |
8 |
|
circulating tumor dna |
8 |
|
contrast media |
8 |
|
convolutional neural network |
8 |
|
curriculum |
8 |
|
diffusion weighted imaging |
8 |
|
direct flow |
8 |
|
fdg-pet/ct |
8 |
|
fiber tracking |
8 |
|
functional brain network |
8 |
|
hfpef |
8 |
|
impacted third molar |
8 |
|
intraventricular flow |
8 |
|
long covid |
8 |
|
longitudinal real-time monitoring |
8 |
|
low-dose protocols |
8 |
|
magnetic resonance cholangiography |
8 |
|
mandibular canal |
8 |
|
multi-detector computed tomography |
8 |
|
neuromyelitis optica |
8 |
|
non-invasive biomarker |
8 |
|
non-metastatic |
8 |
|
oesophageal cancer |
8 |
|
oesophageal squamous cell carcinoma |
8 |
|
oesophagectomy |
8 |
|
olfactory training |
8 |
|
parkinson's disease |
8 |
|
periodontal ligament |
8 |
|
positron-emission tomography and computed tomography |
8 |
|
prognostic factors |
8 |
|
quantitative susceptibility mapping |
8 |
|
residual volume |
8 |
|
screening |
8 |
|
silver |
8 |
|
smell loss |
8 |
|
suv |
8 |
|
systemic lupus erythematosus |
8 |
|
ultralow-field mri |
8 |
|
ultrasound |
8 |
|
adolescent |
7 |
|
advanced escc |
7 |
|
aged, 80 and over |
7 |
|
alkaline phosphatase |
7 |
|
animals |
7 |
|
aorta |
7 |
|
arterial spin labeling |
7 |
|
azygos vein blood |
7 |
|
biliary |
7 |
|
c-reactive protein - analysis |
7 |
|
cell-free dna |
7 |
|
cholangiogram |
7 |
|
chronic kidney disease |
7 |
|
circulating tumor cells |
7 |
|
circulating tumor cells (ctc) |
7 |
|
ctc clusters |
7 |
|
ctc enumeration |
7 |
|
diffusion magnetic resonance imaging - methods |
7 |
|
diffusion tensor imaging - methods |
7 |
|
dti |
7 |
|
early prediction |
7 |
|
emt |
7 |
|
epidemiology |
7 |
|
epithelioid |
7 |
|
gestational |
7 |
|
histogram analysis |
7 |
|
intracerebral hemorrhage |
7 |
|
ketamine |
7 |
|
lipid |
7 |
|
lymph node metastasis |
7 |
|
medical sciences |
7 |
|
medical students |
7 |
|
mild cognitive impairment |
7 |
|
npc |
7 |
|
oral cancer |
7 |
|
oral leukoplakia |
7 |
|
oral lichenoid lesions |
7 |
|
phantoms, imaging |
7 |
|
predictive value of tests |
7 |
|
public health |
7 |
|
specific absorption rate |
7 |
|
substance abuse |
7 |
|
surgery |
7 |
|
tissue contrast |
7 |
|
tomography, spiral computed |
7 |
|
tomography, x-ray computed |
7 |
|
trophoblastic |
7 |
|
ultra-low-field |
7 |
|
uterine cervical neoplasms |
7 |
|
adenocarcinoma |
6 |
|
alff |
6 |
|
alzheimer disease - pathology |
6 |
|
aorta, thoracic - pathology - radiography |
6 |
|
aortic diseases - epidemiology - radiography |
6 |
|
arterial calcification |
6 |
|
arthritis, rheumatoid - complications |
6 |
|
asymptomatic |
6 |
|
atherosclerosis - epidemiology - physiopathology - radiography |
6 |
|
atherosclerosis - epidemiology - radiography |
6 |
|
biological markers - analysis |
6 |
|
biomarker |
6 |
|
body mass index |
6 |
|
bone marrow |
6 |
|
c-reactive protein |
6 |
|
calcinosis - complications - epidemiology - radiography |
6 |
|
calcinosis - epidemiology - physiopathology - radiography |
6 |
|
calcinosis - etiology - radiography |
6 |
|
cardiovascular diseases - epidemiology - physiopathology - radiography |
6 |
|
cardiovascular system - pathology - physiopathology - radiography |
6 |
|
carotid arteries - pathology - radiography |
6 |
|
carotid artery diseases - epidemiology - radiography |
6 |
|
carotid artery diseases - epidemiology - ultrasonography |
6 |
|
carotid artery, common - radiography |
6 |
|
cerebral microbleeds |
6 |
|
cerebral small vessel disease |
6 |
|
cest |
6 |
|
comparative effectiveness |
6 |
|
computer tomography |
6 |
|
concurrent chemoradiotherapy |
6 |
|
coronary angiography |
6 |
|
coronary artery disease - epidemiology - radiography |
6 |
|
coronary artery disease - etiology - radiography |
6 |
|
coronary vessels - pathology |
6 |
|
cross-sectional studies |
6 |
|
diastolic function |
6 |
|
diffusional kurtosis imaging |
6 |
|
diffusivity |
6 |
|
disease progression |
6 |
|
dwi |
6 |
|
extracellular matrix |
6 |
|
extranodal |
6 |
|
extranodal extension |
6 |
|
family |
6 |
|
functional mri |
6 |
|
glioblastoma |
6 |
|
half-life clearance |
6 |
|
hardiness |
6 |
|
head and neck cancers |
6 |
|
herbal medicine |
6 |
|
high cardiovascular risk |
6 |
|
hippocampus |
6 |
|
intervention research |
6 |
|
intervertebral disc |
6 |
|
intra-abdominal fat |
6 |
|
iron deposition |
6 |
|
ischemic stroke |
6 |
|
ivim |
6 |
|
kidney |
6 |
|
liver |
6 |
|
logistic models |
6 |
|
low-level laser irradiation |
6 |
|
lungquality of life |
6 |
|
lupus erythematosus, systemic - complications - physiopathology |
6 |
|
medicine |
6 |
|
meta-analysis |
6 |
|
multimodal |
6 |
|
multiple sclerosis |
6 |
|
myelin |
6 |
|
neoadjuvant chemoradiotherapy |
6 |
|
neoplasm staging |
6 |
|
nerve fibers, myelinated - pathology |
6 |
|
neural network |
6 |
|
nodal staging |
6 |
|
obstructive sleep apnea |
6 |
|
oncology |
6 |
|
orthodontic pain |
6 |
|
orthodontic-periodontal joint treatment |
6 |
|
osteoarthritis |
6 |
|
palliative |
6 |
|
periodontal inflammation |
6 |
|
plasma epstein–barr virus deoxyribonucleic acid |
6 |
|
polycystic kidney disease |
6 |
|
positron-emission tomography and computed tomography - methods |
6 |
|
prognostic factor |
6 |
|
prognostication |
6 |
|
prostate cancer |
6 |
|
psoriasis |
6 |
|
psoriasis - epidemiology |
6 |
|
psychological health |
6 |
|
psychometric validation |
6 |
|
radiogenomic |
6 |
|
randomised clinical trial |
6 |
|
rct |
6 |
|
recurrence |
6 |
|
regression analysis |
6 |
|
repetitive transcranial magnetic stimulation |
6 |
|
resilience |
6 |
|
resting state |
6 |
|
retrogenesis |
6 |
|
retrospective studies |
6 |
|
scleroderma, systemic - complications - radiography |
6 |
|
segmentation |
6 |
|
sleep apnea, obstructive - metabolism |
6 |
|
stress cardiac magnetic resonance |
6 |
|
texture analysis |
6 |
|
tomography |
6 |
|
traditional chinese medicine |
6 |
|
ultrasonography |
6 |
|
ute |
6 |
|
vascular calcification |
6 |
|
vascular dementia |
6 |
|
visceral fat |
6 |
|
visual hallucinations |
6 |
|
visual spatial memory |
6 |
|
waist circumference |
6 |
|
white matter integrity |
6 |
|
18f-flutemetamol |
5 |
|
5-fluorouracil |
5 |
|
[11c]-acetate |
5 |
|
abdominal pregnancy |
5 |
|
accessible mri |
5 |
|
acquired immunodeficiency syndrome - complications - diagnosis |
5 |
|
acupuncture |
5 |
|
adenosine triphosphate |
5 |
|
aetiology |
5 |
|
age-related degenerative disc change |
5 |
|
amygdala |
5 |
|
apparent diffusion coefficient |
5 |
|
basal ganglia |
5 |
|
bone marrow - pathology |
5 |
|
bssfp |
5 |
|
c6 glioma |
5 |
|
calcinosis - pathology - radiography |
5 |
|
capecitabine |
5 |
|
carcinosarcoma |
5 |
|
cerebral blood flow |
5 |
|
cerebral microbleed |
5 |
|
cervical spinal cord |
5 |
|
cetuximab |
5 |
|
child |
5 |
|
class iii malocclusion |
5 |
|
compressed sensing |
5 |
|
coronary artery disease - complications - radiography |
5 |
|
cryptococcosis - diagnosis - etiology |
5 |
|
ct |
5 |
|
dentistry |
5 |
|
diagnosis and treatment |
5 |
|
diagnostic accuracy |
5 |
|
diagnostic imaging |
5 |
|
diffusion weighting |
5 |
|
disc degeneration |
5 |
|
disease-free survival |
5 |
|
dynamic contrast-enhanced magnetic resonance imaging |
5 |
|
dysphagia |
5 |
|
ectopic pregnancy |
5 |
|
endplate defect |
5 |
|
fluorine-18-fluorodeoxyglucose |
5 |
|
fluorodeoxyglucose f18 - diagnostic use |
5 |
|
functional assessment |
5 |
|
gastric cancer |
5 |
|
gestational trophoblastic neoplasia |
5 |
|
gist |
5 |
|
glycosaminoglycan |
5 |
|
glycosaminoglycans - metabolism |
5 |
|
hcc |
5 |
|
hemoperitoneum |
5 |
|
hodgkin disease - drug therapy - pathology |
5 |
|
human brain |
5 |
|
hypoxia |
5 |
|
imbalanced datasets |
5 |
|
interval debulking surgery |
5 |
|
intervertebral disc - metabolism |
5 |
|
intervertebral disc - pathology |
5 |
|
knee osteoarthritis |
5 |
|
lactate |
5 |
|
leiomyosarcoma |
5 |
|
liver fibrosis |
5 |
|
lumbar |
5 |
|
lumbar vertebrae - metabolism |
5 |
|
lumbar vertebrae - pathology |
5 |
|
lymphatic diseases - diagnosis - etiology |
5 |
|
lymphoma - diagnosis |
5 |
|
lymphoma, large b-cell, diffuse - drug therapy - pathology |
5 |
|
magnetic |
5 |
|
maxillofacial diseases |
5 |
|
mediastinal neoplasms - drug therapy - pathology |
5 |
|
metastatic |
5 |
|
metastatic colorectal cancer |
5 |
|
molecular size |
5 |
|
multidisciplinary management |
5 |
|
neo-adjuvant chemotherapy |
5 |
|
neuromyelitis optica - diagnosis - pathology |
5 |
|
neurorehabilitation |
5 |
|
pain |
5 |
|
panoramic radiographs |
5 |
|
periodontitis |
5 |
|
peritoneal carcinomatosis |
5 |
|
pet imaging |
5 |
|
pilot projects |
5 |
|
positron-emission tomography - methods |
5 |
|
protocol |
5 |
|
radiographic imaging |
5 |
|
radiotherapy |
5 |
|
random forest |
5 |
|
re-sampling techniques |
5 |
|
renal impairment |
5 |
|
resonance imaging |
5 |
|
rna sequencing |
5 |
|
scleroderma, systemic - complications - pathology |
5 |
|
sex |
5 |
|
sham acupuncture |
5 |
|
sinew acupuncture |
5 |
|
smell training |
5 |
|
spectral overlapping |
5 |
|
spinal cord - pathology |
5 |
|
staging |
5 |
|
statistics, nonparametric |
5 |
|
stress |
5 |
|
stretched exponential |
5 |
|
suvmax |
5 |
|
systemic treatment |
5 |
|
therapeutic evaluation |
5 |
|
tomography, x-ray computed - methods |
5 |
|
treatment failure |
5 |
|
tumour board |
5 |
|
tumour staging |
5 |
|
ultra-low-field mri |
5 |
|
ultrashort time-to-echo |
5 |
|
uterine sarcoma |
5 |
|
vision-language models |
5 |
|
whole-body |
5 |
|
2-[18f]fdg pet/ct |
4 |
|
3d voxels |
4 |
|
abdominal mri |
4 |
|
ablation techniques |
4 |
|
acute leukemia |
4 |
|
adpkd |
4 |
|
adrenal cortex hormones - therapeutic use |
4 |
|
algorithms |
4 |
|
amyloid-β protein (aβ) |
4 |
|
angiography |
4 |
|
anterior cingulate cortex |
4 |
|
antimicrobial resistance |
4 |
|
apoe ɛ4-negative |
4 |
|
apoe4 |
4 |
|
asia |
4 |
|
autosomal dominant polycystic kidney disease |
4 |
|
b-value |
4 |
|
bioinformatics |
4 |
|
blood volume |
4 |
|
body composition |
4 |
|
bold |
4 |
|
bone marrow - drug effects - pathology - radionuclide imaging |
4 |
|
brain tumor |
4 |
|
cancer management |
4 |
|
cbct |
4 |
|
cell metabolism |
4 |
|
central executive network (cen) |
4 |
|
chatbot |
4 |
|
chatgpt |
4 |
|
checkpoint inhibitor |
4 |
|
chemotherapy response score |
4 |
|
chest radiographs |
4 |
|
child, preschool |
4 |
|
chinese medicine |
4 |
|
citric acid cycle |
4 |
|
classification of proteins |
4 |
|
clinical trial |
4 |
|
colistin |
4 |
|
ct imaging |
4 |
|
data mining |
4 |
|
default mode network (dmn) |
4 |
|
dento-maxillofacial radiology |
4 |
|
diabetes |
4 |
|
diagnostic errors |
4 |
|
diagnostic procedure |
4 |
|
diffusion measurement |
4 |
|
diffusion mri |
4 |
|
diffusion time |
4 |
|
dimensionality reduction |
4 |
|
dynamic contrast enhanced |
4 |
|
early detection |
4 |
|
egfr mutations |
4 |
|
ensemble 3d deep learning |
4 |
|
extramedullary |
4 |
|
fat–water decomposition mri |
4 |
|
fdg |
4 |
|
fdg pet/ct |
4 |
|
fdg-avid lymphoma |
4 |
|
fluorodeoxyglucose f18 |
4 |
|
fluorodeoxyglucose f18 - diagnostic use - pharmacokinetics |
4 |
|
fmri |
4 |
|
follow-up studies |
4 |
|
functional magnetic resonance imaging |
4 |
|
functional neuroimaging |
4 |
|
glucose metabolism |
4 |
|
glutamatergic system |
4 |
|
gpt |
4 |
|
hands-on training |
4 |
|
heart |
4 |
|
hematological toxicity |
4 |
|
high-intensity focused ultrasound ablation |
4 |
|
ileal neoplasms - drug therapy - pathology - radionuclide imaging |
4 |
|
image segmentation |
4 |
|
immune checkpoint inhibitor |
4 |
|
incidence |
4 |
|
indolent lymphoma |
4 |
|
interventional ultrasonography |
4 |
|
intervertebral disc degeneration |
4 |
|
intimate partner violence |
4 |
|
late-onset alzheimer's disease |
4 |
|
lean body mass |
4 |
|
learning |
4 |
|
llms |
4 |
|
low‐density lipoprotein cholesterol |
4 |
|
lymphoma |
4 |
|
magnetic resonance imaging (mri) |
4 |
|
magnetic stimulation |
4 |
|
management |
4 |
|
marrow biopsy |
4 |
|
maxillary sinus |
4 |
|
mcr-1 |
4 |
|
metabolites |
4 |
|
metal-binding sites |
4 |
|
metalloenzymes |
4 |
|
metalloprotein |
4 |
|
metastasis |
4 |
|
mlkl |
4 |
|
monomorphic epitheliotropic intestinal t cell lymphoma |
4 |
|
mr fingerprinting |
4 |
|
mucosal retention cyst |
4 |
|
mucosal thickening |
4 |
|
multiplexed sensitivity encoding |
4 |
|
myeloid sarcoma |
4 |
|
neoadjuvant chemotherapy |
4 |
|
neoplasia |
4 |
|
neoplasm metastasis |
4 |
|
neoplasm, residual |
4 |
|
neurological impact |
4 |
|
nodular goiter |
4 |
|
normal-appearing brain tissues |
4 |
|
omics |
4 |
|
oral cavity cancer |
4 |
|
orthodontics |
4 |
|
ovarian neoplasms |
4 |
|
peritoneal neoplasms |
4 |
|
pneumonia |
4 |
|
point-of-care ultrasound |
4 |
|
positron emission tomography computed tomography |
4 |
|
post-chemoradiation fibrosis |
4 |
|
post-stroke dysphagia |
4 |
|
prospective cohort study |
4 |
|
proteinuria |
4 |
|
proteoglycan |
4 |
|
psychological stress |
4 |
|
quantitative analysis |
4 |
|
quantitative mri analysis |
4 |
|
radiation dosage |
4 |
|
radiation dose |
4 |
|
radiopharmaceuticals - diagnostic use |
4 |
|
radiopharmaceuticals - diagnostic use - pharmacokinetics |
4 |
|
rat |
4 |
|
relaxometry |
4 |
|
relayed nuclear overhauser effect (rnoe) |
4 |
|
reproducibility of results |
4 |
|
resting state functional mri (rsmri) |
4 |
|
restricted diffusion |
4 |
|
salience network (sn) |
4 |
|
sarcoma, myeloid - drug therapy - pathology - radionuclide imaging |
4 |
|
sarcoma, myeloid - pathology - radionuclide imaging |
4 |
|
scoping review |
4 |
|
self-referential network (srn) |
4 |
|
semi-supervised learning |
4 |
|
semiquantitative analysis |
4 |
|
sensory motor network (smn) |
4 |
|
southern chinese |
4 |
|
spatial features |
4 |
|
stage iv |
4 |
|
stereotactic ablative radiation therapy |
4 |
|
stereotactic radiation therapy |
4 |
|
target therapy |
4 |
|
teaching |
4 |
|
tetralogy of fallot |
4 |
|
thigh muscle segmentation |
4 |
|
time-to-event |
4 |
|
tooth identification |
4 |
|
tooth segmentation |
4 |
|
transformer neural network |
4 |
|
tumor staging |
4 |
|
tumour stage |
4 |
|
valvular heart disease |
4 |
|
white matter hyperintensities |
4 |
|
whole exome sequencing |
4 |
|
whole-body mri |
4 |
|
x-ray computed |
4 |
|
x-ray computed tomography |
4 |
|
young adult |
4 |
|
acute disease |
3 |
|
acute kidney injury |
3 |
|
aflibercept |
3 |
|
american joint committee on cancer stages |
3 |
|
amyloidosis - diagnosis - etiology - pathology - radionuclide imaging |
3 |
|
angiogram |
3 |
|
appendicitis |
3 |
|
area under the curve |
3 |
|
artificial embolism |
3 |
|
artificial neural network |
3 |
|
b-values |
3 |
|
beam motion control |
3 |
|
bgcs |
3 |
|
bone |
3 |
|
bone-to-implant contact |
3 |
|
brain functional connectivity |
3 |
|
brain topological organisation |
3 |
|
brainstem atrophy |
3 |
|
brainstem regional volume |
3 |
|
calcinosis - etiology - radionuclide imaging |
3 |
|
carcinoma - radiotherapy |
3 |
|
cardiac capacity |
3 |
|
cardiac imaging |
3 |
|
cardiac magnetic resonance imaging |
3 |
|
cardiac mri |
3 |
|
cardiorespiratory fitness |
3 |
|
cardiotoxicity |
3 |
|
causal inference |
3 |
|
cell differentiation |
3 |
|
cephalometry |
3 |
|
cerebral infarction |
3 |
|
cerebral perfusion |
3 |
|
cervical carcinoma |
3 |
|
cest mri |
3 |
|
chinese herbal medicine |
3 |
|
cholangiocarcinoma |
3 |
|
circulating haemoglobin mass |
3 |
|
clinical assessment |
3 |
|
cognitive dysfunctions |
3 |
|
coils |
3 |
|
colorectal neoplasms |
3 |
|
comparability |
3 |
|
complete metabolic response |
3 |
|
computational biology |
3 |
|
computed tomography (ct), contrast enhancement |
3 |
|
cone beam |
3 |
|
cone beam computed tomography |
3 |
|
cone beam computerized tomography |
3 |
|
corpus callosum |
3 |
|
cranial nerves |
3 |
|
cyclegan |
3 |
|
cyclophosphamide - therapeutic use |
3 |
|
cytoreduction |
3 |
|
damage control resuscitation |
3 |
|
deauville score (ds) |
3 |
|
difficult airway mangement |
3 |
|
diffusion weighted mrs |
3 |
|
diffusion-weighted mri |
3 |
|
disability |
3 |
|
discriminant analysis |
3 |
|
disease staging |
3 |
|
drug side effect |
3 |
|
drug-target interaction |
3 |
|
dynamic [ 18f]fluoro-2-deoxy-d-glucose pet |
3 |
|
echocardiography |
3 |
|
echocardiography parameters |
3 |
|
edentulous maxilla |
3 |
|
electronic health records |
3 |
|
endometrial carcinoma |
3 |
|
endovascular procedures |
3 |
|
entropy |
3 |
|
epidemiological characteristics |
3 |
|
extranodal natural killer/t-cell lymphoma (enktl) |
3 |
|
fabrication |
3 |
|
fibrosis |
3 |
|
figo |
3 |
|
first-episode schizophrenia |
3 |
|
fluorodeoxyglucose f 18 |
3 |
|
fluorodeoxyglucose f18 - pharmacology |
3 |
|
functional mrs |
3 |
|
gamma-aminobutyric acid |
3 |
|
genome-wide association studies |
3 |
|
germinoma |
3 |
|
germinomas |
3 |
|
glutamate |
3 |
|
gradient echo |
3 |
|
graph representation learning |
3 |
|
hans chinese |
3 |
|
heart failure |
3 |
|
heart rate |
3 |
|
hematoma |
3 |
|
hepatotoxicity |
3 |
|
hernia |
3 |
|
histologic subtypes |
3 |
|
histopathologic features |
3 |
|
hybrid control |
3 |
|
hydrogel |
3 |
|
hydronephrosis |
3 |
|
idiopathic pulmonary fibrosis |
3 |
|
image enhancement - methods |
3 |
|
image processing, computer-assisted |
3 |
|
image reconstruction |
3 |
|
imatinib |
3 |
|
immunoglobulin lambda-chains - analysis |
3 |
|
immunosuppressive agents |
3 |
|
inferior colliculus |
3 |
|
learning-based modulation |
3 |
|
left ventricular function |
3 |
|
liposome |
3 |
|
liver toxicity |
3 |
|
low-income countries |
3 |
|
lower-middle-income countries |
3 |
|
lupus nephritis - diagnosis |
3 |
|
lymph nodes - pathology - radionuclide imaging |
3 |
|
lymphatic diseases - etiology - pathology - radionuclide imaging |
3 |
|
lymphoepithelioma-like carcinoma |
3 |
|
lymphoma, large b-cell, diffuse - pathology - therapy |
3 |
|
mantle cell lymphoma |
3 |
|
marek disease - diagnosis - etiology - radionuclide imaging |
3 |
|
mcnamara's analysis |
3 |
|
measurement |
3 |
|
mesenteric veins |
3 |
|
metagenomic sequencing |
3 |
|
metformin |
3 |
|
microbial communities |
3 |
|
mr angiography |
3 |
|
mr spectroscopic imaging |
3 |
|
multi-task learning |
3 |
|
multiple sclerosis (ms) |
3 |
|
multivariate analysis |
3 |
|
muscle |
3 |
|
myocarditis |
3 |
|
nasopharyngeal neoplasms - metabolism - pathology - radionuclide imaging - therapy |
3 |
|
nasopharyngeal neoplasms - metabolism - radionuclide imaging |
3 |
|
nasopharyngeal neoplasms - metabolism - radiotherapy |
3 |
|
neoplasm invasiveness - pathology |
3 |
|
nephrotic syndrome |
3 |
|
neurodegeneration |
3 |
|
neuroinflammation |
3 |
|
neurolymphomatosis |
3 |
|
neuromodulation |
3 |
|
neuromyelitis optica spectrum disorders |
3 |
|
neuromyelitis optica spectrum disorders (nmosd) |
3 |
|
neuropsychological assessment |
3 |
|
older age |
3 |
|
ophthalmic specialty clinics |
3 |
|
oral arsenic trioxide |
3 |
|
oral microbiome |
3 |
|
ovarian and peritoneal cancers |
3 |
|
ovarian carcinoma |
3 |
|
parallel imaging |
3 |
|
paraproteinemias - complications - diagnosis |
3 |
|
paraproteins - analysis |
3 |
|
percist |
3 |
|
perfusion imaging |
3 |
|
peritoneal pelvic packing |
3 |
|
permeability |
3 |
|
pet |
3 |
|
portal vein |
3 |
|
positron emission tomography-computed tomography |
3 |
|
positron-emission tomography - methods - utilization - veterinary |
3 |
|
pressure gradient manipulation |
3 |
|
prevalence in south-eastern chinese |
3 |
|
primary aldosteronism |
3 |
|
principal component analysis |
3 |
|
prognostic indicators |
3 |
|
prognostic marker |
3 |
|
prospective studies |
3 |
|
prostate |
3 |
|
proteinuria - drug therapy - etiology |
3 |
|
proton magnetic resonance spectroscopy |
3 |
|
psychiatry and neurology gerontology and geriatrics |
3 |
|
psychosis |
3 |
|
public health care system |
3 |
|
q-factor |
3 |
|
recovered |
3 |
|
recurrence detection |
3 |
|
refractory |
3 |
|
refractory hypertension |
3 |
|
regional adiposity |
3 |
|
relapsed |
3 |
|
renal cell carcinoma |
3 |
|
reproducibility |
3 |
|
resistant hypertension |
3 |
|
resnet |
3 |
|
response assessment |
3 |
|
response criteria |
3 |
|
response evaluation |
3 |
|
resting state functional mri |
3 |
|
resting-state functional magnetic resonance |
3 |
|
right ventricular function |
3 |
|
robot-assisted mrg-fus |
3 |
|
rosai-dorfman disease |
3 |
|
rucam |
3 |
|
run length |
3 |
|
salivary glands tumor |
3 |
|
secondary metabolites |
3 |
|
serum uric acid |
3 |
|
severity of illness index |
3 |
|
sex dimorphism |
3 |
|
side effect |
3 |
|
silent lacunes |
3 |
|
single-blind method |
3 |
|
sjogren's syndrome - diagnosis - etiology - pathology |
3 |
|
spin echo |
3 |
|
spine |
3 |
|
squamous cell carcinoma |
3 |
|
stroke - epidemiology |
3 |
|
survivors |
3 |
|
susceptibility weighted imaging |
3 |
|
synthetic magnetic resonance imaging |
3 |
|
systematic review |
3 |
|
systemic therapy |
3 |
|
target organ damage |
3 |
|
thrombophlebitis |
3 |
|
time factors |
3 |
|
total kidney volume |
3 |
|
total lesion glycolysis |
3 |
|
triage |
3 |
|
tricuspid regurgitation |
3 |
|
troponin |
3 |
|
tumor burden |
3 |
|
tumor debulking |
3 |
|
tumor heterogeneity |
3 |
|
type 2 diabetes mellitus |
3 |
|
type 2 diabetic mellitus |
3 |
|
untreated hypertension |
3 |
|
uterine cervical neoplasms - pathology - therapy |
3 |
|
v-net |
3 |
|
vagus nerve |
3 |
|
vascular cognitive impairment |
3 |
|
venous return |
3 |
|
volumetry |
3 |
|
voxel-mirrored homotopic connectivity |
3 |
|
wireless communication |
3 |
|
zygomatic implants |
3 |
|
zygomatic thickness |
3 |
|
18f-fdg pet/ ct |
2 |
|
3d diffusion‐weighted imaging |
2 |
|
3d interleaved epi |
2 |
|
3d phase correction |
2 |
|
3d printing |
2 |
|
4d imaging |
2 |
|
68ga |
2 |
|
abdomen -- imaging. |
2 |
|
abdominal ct |
2 |
|
abiraterone (aa) |
2 |
|
absolute quantification |
2 |
|
acupuncture points |
2 |
|
acupuncture therapy |
2 |
|
acute appendicitis |
2 |
|
adjuvant chemotherapy |
2 |
|
altitude |
2 |
|
altitude sickness |
2 |
|
alzheimer's disease - magnetic resonance imaging |
2 |
|
analysis |
2 |
|
analysis of variance |
2 |
|
ankylosing spondylitis |
2 |
|
anti-thyroglobulin autoantibody |
2 |
|
anticoagulants |
2 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
2 |
|
aorta, ct |
2 |
|
apalutamide |
2 |
|
apd |
2 |
|
aphasia |
2 |
|
aphasia - etiology - psychology - radiography - therapy |
2 |
|
arteries |
2 |
|
arteriovenous anastomosis - pathology |
2 |
|
arteriovenous malformation |
2 |
|
artifact removal |
2 |
|
artificial intelligence (ai) |
2 |
|
asian continental ancestry group |
2 |
|
astrocytoma |
2 |
|
atypical pneumonia |
2 |
|
automated segmentation |
2 |
|
autosomal dominant polycystic kidney disease (adpkd) |
2 |
|
awake |
2 |
|
axial spondyloarthritis |
2 |
|
balloon test occlusion |
2 |
|
bayesian estimation |
2 |
|
behcet disease |
2 |
|
behcet syndrome - radionuclide imaging |
2 |
|
benign |
2 |
|
benign and reactive |
2 |
|
benign thyroid nodule |
2 |
|
bile duct neoplasms - complications - radionuclide imaging |
2 |
|
biopsy, fine-needle |
2 |
|
blood oxygenation level-dependent |
2 |
|
blood-brain barrier |
2 |
|
body burden |
2 |
|
body water |
2 |
|
bowel |
2 |
|
brain abscess |
2 |
|
brain cortex |
2 |
|
brain edema |
2 |
|
brain imaging |
2 |
|
brain injuries - pathology |
2 |
|
brain ischemia - diagnosis - etiology |
2 |
|
brain ischemia - drug therapy - epidemiology - radiography |
2 |
|
brain ischemia - epidemiology |
2 |
|
brain malformation |
2 |
|
brain mapping |
2 |
|
brain metabolites |
2 |
|
brain neoplasms - blood supply - metabolism - pathology - secondary |
2 |
|
brain network |
2 |
|
breast |
2 |
|
breast neoplasms |
2 |
|
cad |
2 |
|
calcinosis - epidemiology - ethnology - radiography |
2 |
|
cancer incidence |
2 |
|
cancer mortality |
2 |
|
cancer patient |
2 |
|
cancer related symptoms |
2 |
|
cancer risk |
2 |
|
cancer survival |
2 |
|
capillary permeability |
2 |
|
capsulenet |
2 |
|
carcinoid tumor |
2 |
|
carcinoma - blood supply - metabolism - pathology - secondary |
2 |
|
carcinoma, renal cell - complications - radionuclide imaging |
2 |
|
carcinomatosis |
2 |
|
cardiac ct |
2 |
|
cardiac magnetic resonance |
2 |
|
cardiac tamponade - etiology |
2 |
|
cardiovascular magnetic resonance imaging |
2 |
|
cardiovascular mortality |
2 |
|
cardiovascular system |
2 |
|
cauda equina |
2 |
|
cbs (carotid blowout syndrome) |
2 |
|
cerebral angiography |
2 |
|
cerebral arteries - pathology - physiopathology - radiography |
2 |
|
cervical nodal necrosis |
2 |
|
chemical exchange saturation transfer |
2 |
|
chest |
2 |
|
chest ct |
2 |
|
chest radiograph |
2 |
|
children |
2 |
|
china |
2 |
|
cholangiocarcinoma - complications - radionuclide imaging |
2 |
|
choline |
2 |
|
chronic kidney failure |
2 |
|
chronic stroke |
2 |
|
chronic urticaria |
2 |
|
classification |
2 |
|
clinical outcome |
2 |
|
cognition disorders |
2 |
|
cohort studies |
2 |
|
collagenase |
2 |
|
combined modality therapy |
2 |
|
comprehension - physiology |
2 |
|
computed tomography (ct) |
2 |
|
computed tomography (ct), contrast media |
2 |
|
computed tomography (ct), image processing |
2 |
|
computed tomography (ct), technology |
2 |
|
computed tomography (ct), three-dimensional |
2 |
|
computer automatic diagnosis |
2 |
|
computer-aided diagnosis (cad) |
2 |
|
contrast agents |
2 |
|
contrast media - administration and dosage |
2 |
|
contrast media - diagnostic use |
2 |
|
contrast media, experimental studies |
2 |
|
convolution neural network |
2 |
|
cord compression |
2 |
|
coronary angiography - methods - statistics & numerical data |
2 |
|
coronary microvascular disease |
2 |
|
cortical |
2 |
|
cortisol |
2 |
|
cranioplasty |
2 |
|
craniospinal irradiation |
2 |
|
ct coronary angiography |
2 |
|
cu-q2ol |
2 |
|
data consistency |
2 |
|
decompressive craniectomy |
2 |
|
deep brain stimulation |
2 |
|
deep learning reconstruction |
2 |
|
diagnostic signs |
2 |
|
diagnostics |
2 |
|
diffusion magnetic resonance spectroscopy |
2 |
|
diffusion‐weighted imaging |
2 |
|
distant metastasis |
2 |
|
docetaxel |
2 |
|
dota |
2 |
|
drain |
2 |
|
dropout |
2 |
|
dura mater - pathology |
2 |